HomeRCUS • NYSE
add
Arcus Biosciences Inc
Previous close
$8.01
Day range
$7.62 - $7.94
Year range
$6.50 - $18.98
Market cap
836.15M USD
Avg Volume
1.10M
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 26.00M | -16.13% |
Operating expense | 28.00M | -3.45% |
Net income | -94.00M | -16.05% |
Net profit margin | -361.54 | -38.37% |
Earnings per share | -1.03 | 4.63% |
EBITDA | -100.00M | -13.64% |
Effective tax rate | -1.08% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 978.00M | 28.85% |
Total assets | 1.15B | 5.02% |
Total liabilities | 665.00M | 5.06% |
Total equity | 485.00M | — |
Shares outstanding | 105.84M | — |
Price to book | 1.52 | — |
Return on assets | -21.44% | — |
Return on capital | -39.98% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -94.00M | -16.05% |
Cash from operations | -100.00M | -13.64% |
Cash from investing | 51.00M | 82.14% |
Cash from financing | -2.00M | -166.67% |
Net change in cash | -51.00M | 10.53% |
Free cash flow | -36.62M | 25.06% |
About
Founded
2015
Website
Employees
627
